Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
scientific article
Author/s
author: Ashraf Elghandour, Monika Sopala, Hans Salwender, Enrique M Ocio, Hareth Nahi, Javier de la Rubia, Krzysztof Warzocha, Paolo Corradini, Athanasios Dimopoulos, Sagar Lonial, Hermann Einsele, Paul G. Richardson, Philippe Moreau, Wieslaw Jedrzejczak, Kwee L Yong, Jamie D Cavenagh, Joan Bladé, Vania Hungria, Thanyaphong Na Nakorn, Noppadol Siritanaratkul, Robert Schlossman, Lugui Qiu, Peter Gimsing, Claudia Corrado, Bourras-Rezki Bengoudifa, Florence Binlich, Jonathan L Kaufman, Wenming Chen, Jesús San Miguel, Meral Beksaç
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.